Emerging Growth Patterns Driving Expansion in the Tissue Microarray Market

The tissue microarray sector is positioned for substantial growth in the near future, driven by advances in biomedical research and technology. With increasing investments and innovative applications, this market is expected to transform various facets of oncology and diagnostic science. Here, we explore the market's size, key players, emerging trends, and segmentation to provide a comprehensive picture of its trajectory.

Projected Market Size and Growth in the Tissue Microarray Market
The tissue microarray market is forecasted to expand swiftly, reaching a valuation of $23.61 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 12.6%. Several factors are fueling this rise, including intensified funding in precision oncology studies, growing use of digital pathology tools, the broadening of translational research activities, and an increasing reliance on tissue microarrays in drug discovery. Noteworthy trends that are expected to define the market include enhanced use of high-throughput tissue analysis systems, the widespread adoption of multiplex immunohistochemistry techniques, rising demand for standardized tissue arrays, the growth of automated tissue microarray production, and stronger integration with molecular diagnostics platforms.

Download a free sample of the tissue microarray market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Leading Industry Players in the Tissue Microarray Market
The tissue microarray market features several prominent companies driving innovation and supply. These include BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, and iSpecimen Inc.
In a significant development in May 2024, Bruker Corporation, a US-based supplier of high-end scientific instruments, acquired NanoString Technologies for about $392.6 million. This acquisition aims to bolster Bruker's spatial biology and transcriptomics capabilities and reinforce its leadership in high-plex tissue analysis. NanoString Technologies is recognized for its platforms focused on spatial transcriptomics, single-cell imaging, and gene-expression analysis, widely utilized in whole-tissue and tissue microarray research.

Emerging Trends Shaping the Tissue Microarray Market
Market leaders are emphasizing the development of advanced microarray platforms to improve precision and throughput in tissue analysis. These platforms enable simultaneous examination of multiple genes or biomolecules on a compact surface, facilitating intricate genetic and expression studies.
For example, in June 2023, MARGenomics, a research institute affiliated with Hospital del Mar in Spain, introduced the Applied Biosystems GeneChip 3000 Dx v2. Supported by the Carlos III Health Institute and the EU's NextGenerationEU program, this microarray platform is the first in Europe and the US to achieve IVD-R certification for diagnostic use. It supports a broad range of genomic and expression microarray functions, marking a significant milestone in diagnostic technology.

View the full tissue microarray market report:
https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Mar_PR

Segment Breakdown of the Global Tissue Microarray Market
The report categorizes the tissue microarray market into several key segments:
1) Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, and Other Types
2) Technology: Immunohistochemistry (IHC)-Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies
3) Application: Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies
4) End-User: Pharmaceutical and Biotechnological Companies, Research Organizations, Hospitals

Further subcategories include:
- Immunohistochemistry: Automated, Manual, Multiplex
- Fluorescent In Situ Hybridization (FISH): Single-Color, Multi-Color, DNA FISH
- Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
- Other Types: RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

This segmentation offers a detailed framework for understanding the diverse technologies, applications, and end-user groups fueling the growth of the tissue microarray market.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.